Discover

GRI
GRI Bio, Inc.
1.51
1 x 1.38
1 x 1.62
bid
ask
+
0.04
2.72%
100 @ 04:00 PM
1.50 -0.01 (0.66%)
Ytd-78.15%
1y-97.29%
1.43
day range
1.53
1.42
52 week range
80.36
Open1.46Prev Close1.47Low1.43High1.53Mkt Cap135.65K
Vol17.99KAvg Vol65.73KEPS-52.02P/E-0.03Forward P/E-0.29
Beta-1.21Short Ratio0.10Inst. Own4.71%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg1.98200-d Avg15.461yr Est11.50
Income Statement
Operating Expenses2.00M
Research and Development Expense361.00K
Selling, General and Administrative Expense1.64M
Operating Income-2.00M
Net Income-2.00M
Net Income Common Stock-2.00M
Net Income Common Stock (USD)-2.00M
Consolidated Income-2.00M
Earnings per Basic Share-1.61
Earnings per Basic Share (USD)-1.61
Earnings per Diluted Share-1.61
Earning Before Interest & Taxes (EBIT)-2.00M
Earning Before Interest & Taxes (USD)-2.00M
Weighted Average Shares1.24M
Weighted Average Shares Diluted1.24M
Balance Sheet
Cash and Equivalents11.05M
Cash and Equivalents (USD)11.05M
Current Assets11.28M
Property, Plant & Equipment Net60.00K
Total Assets11.34M
Debt Current58.00K
Total Debt58.00K
Current Liabilities794.00K
Total Liabilities794.00K
Accumulated Retained Earnings (Deficit)-53.69M
Shareholders Equity10.55M
Shareholders Equity (USD)10.55M
Assets Non-Current60.00K
Total Debt (USD)58.00K
Trade and Non-Trade Payables303.00K
Cash Flow
Depreciation, Amortization & Accretion1000
Net Cash Flow from Financing6.50M
Net Cash Flow / Change in Cash & Cash Equivalents2.82M
Issuance (Purchase) of Equity Shares6.50M
Net Cash Flow from Operations-3.68M
Share Based Compensation31.00K